Toll Free: 1-888-928-9744

Galapagos NV - Product Pipeline Review - 2016

Published: Jul, 2016 | Pages: 64 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Galapagos NV - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Galapagos NV - Product Pipeline Review - 2016', provides an overview of the Galapagos NV's pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Galapagos NV, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Galapagos NV
- The report provides overview of Galapagos NV including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Galapagos NV's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Galapagos NV's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Galapagos NV's strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Galapagos NV
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Galapagos NV's pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
 Table of Contents
Table of Contents 2 List of Tables 5 List of Figures 5 Galapagos NV Snapshot 6 Galapagos NV Overview 6 Key Information 6 Key Facts 6 Galapagos NV - Research and Development Overview 7 Key Therapeutic Areas 7 Galapagos NV - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Pipeline Products - Combination Treatment Modalities 12 Pipeline Products - Partnered Products 13 Partnered Products/Combination Treatment Modalities 14 Pipeline Products - Out-Licensed Products 15 Out-Licensed Products/Combination Treatment Modalities 16 Galapagos NV - Pipeline Products Glance 17 Galapagos NV - Clinical Stage Pipeline Products 17 Phase II Products/Combination Treatment Modalities 17 Phase I Products/Combination Treatment Modalities 18 Galapagos NV - Early Stage Pipeline Products 19 Preclinical Products/Combination Treatment Modalities 19 Discovery Products/Combination Treatment Modalities 20 Galapagos NV - Drug Profiles 21 filgotinib 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 GLPG-1205 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 GLPG-1690 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 GLPG-1837 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 DT-200 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 GLPG-1972 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 GLPG-2222 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 GLPG-2451 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 MOR-106 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 GLPG-1492 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 GLPG-1790 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 GLPG-1837 + GLPG-2222 + GLPG-2665 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 GLPG-2534 39 Product Description 39 Mechanism of Action 39 R&D Progress 39 GLPG-2665 40 Product Description 40 Mechanism of Action 40 R&D Progress 40 GLPG-2737 41 Product Description 41 Mechanism of Action 41 R&D Progress 41 GLPG-2851 42 Product Description 42 Mechanism of Action 42 R&D Progress 42 GLPG-2938 43 Product Description 43 Mechanism of Action 43 R&D Progress 43 Galapagos NV - Pipeline Analysis 44 Galapagos NV - Pipeline Products by Target 44 Galapagos NV - Pipeline Products by Route of Administration 45 Galapagos NV - Pipeline Products by Molecule Type 46 Galapagos NV - Pipeline Products by Mechanism of Action 47 Galapagos NV - Recent Pipeline Updates 48 Galapagos NV - Dormant Projects 60 Galapagos NV - Discontinued Pipeline Products 61 Discontinued Pipeline Product Profiles 61 GLPG-0187 61 GLPG-0259 61 GLPG-1179 61 GLPG-1205 61 GLPG-1332 61 GLPG-1577 61 Galapagos NV - Locations And Subsidiaries 62 Head Office 62 Other Locations & Subsidiaries 62 Appendix 63 Methodology 63 Coverage 63 Secondary Research 63 Primary Research 63 Expert Panel Validation 63 Contact Us 63 Disclaimer 64
List of Tables
Galapagos NV, Key Information 6 Galapagos NV, Key Facts 6 Galapagos NV - Pipeline by Indication, 2016 8 Galapagos NV - Pipeline by Stage of Development, 2016 10 Galapagos NV - Monotherapy Products in Pipeline, 2016 11 Galapagos NV - Combination Treatment Modalities in Pipeline, 2016 12 Galapagos NV - Partnered Products in Pipeline, 2016 13 Galapagos NV - Partnered Products/ Combination Treatment Modalities, 2016 14 Galapagos NV - Out-Licensed Products in Pipeline, 2016 15 Galapagos NV - Out-Licensed Products/ Combination Treatment Modalities, 2016 16 Galapagos NV - Phase II, 2016 17 Galapagos NV - Phase I, 2016 18 Galapagos NV - Preclinical, 2016 19 Galapagos NV - Discovery, 2016 20 Galapagos NV - Pipeline by Target, 2016 44 Galapagos NV - Pipeline by Route of Administration, 2016 45 Galapagos NV - Pipeline by Molecule Type, 2016 46 Galapagos NV - Pipeline Products by Mechanism of Action, 2016 47 Galapagos NV - Recent Pipeline Updates, 2016 48 Galapagos NV - Dormant Developmental Projects,2016 60 Galapagos NV - Discontinued Pipeline Products, 2016 61 Galapagos NV, Subsidiaries 62



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify